4.7 Review

Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for 'two-in-one' cancer chemoimmunotherapeutics

期刊

CANCER LETTERS
卷 369, 期 1, 页码 9-19

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.07.047

关键词

Anti-tumor immunity; AS-PKAI; Chemoimmunotherapeutics; Immunosurveillance; 'Two-in-one'; Tumor reversion

类别

资金

  1. CAS-TWAS President's Fellowship

向作者/读者索取更多资源

An emerging trend in cancer chemoimmunotherapeutics is to develop 'two-in-one' therapies, which directly inhibit tumor growth and progression, as well as enhance anti-tumor immune surveillance. Protein kinase A (PICA) is a cAMP-dependent protein kinase that mediates signal transduction of G-protein coupled receptors (GPCRs). The regulatory subunit of PICA exists in two isoforms, RI and Rh, which distinguish the PICA isozymes, PICA type I (PKAI) and PICA type II (PICAII). The differential expression of both PICA isozymes has long been linked to growth regulation and differentiation. RI/PKAI is particularly implicated in cellular proliferation and neoplastic transformation. Emerging experimental and pre-clinical data also indicate that RI/PKAI plays a key role in tumor-induced immune suppression. More briefly, RI/PICA' possesses a dichotomous role in the tumor microenvironment: not only contributes to tumor growth and progression, but also takes part in tumor-induced suppression of the innate and adaptive arms of antitumor immunosurveillance. This review specifically discusses this dichotomous role of RI/PKAI with respect to 'two-in-one' chemoimmunotherapeutic manipulation. The reviewed experimental and pre-clinical data provide the proof of concept validation that RI/PKAI may be regarded as an attractive target for a new, single-targeted, 'two hit' chemoimmunotherapeutic approach against cancer. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery

Muzammal Hussain, Yongzhi Lu, Yong-Qiang Liu, Kai Su, Jiancun Zhang, Jinsong Liu, Guang-Biao Zhou

PHARMACOLOGICAL RESEARCH (2016)

Article Biochemistry & Molecular Biology

Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors

Yuyang Ding, Fei Tang, Xiaoqian Xue, Jinfeng Luo, Muzammal Hussain, Yanhui Huang, Zhen Wang, Hao Jiang, Zhengchao Tu, Jiancun Zhang

BIOORGANIC CHEMISTRY (2019)

Review Medicine, Research & Experimental

CXCL13/CXCR5 signaling axis in cancer

Muzammal Hussain, Dickson Adah, Muqddas Tariq, Yongzhi Lu, Jiancun Zhang, Jinsong Liu

LIFE SCIENCES (2019)

Article Biochemistry & Molecular Biology

Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage

Nasir Abbas, Anteneh Getachew, Kai You, Zahir Shah, Yan Chen, Jiawang Tao, Muzammal Hussain, Fan Yang, Yuanqi Zhuang, Yingying Xu, Yin-Xiong Li

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target against vascular calcification

Hina Andleeb, Muzammal Hussain, Syeda Abida Ejaz, Jean Sevigny, Muhammad Farman, Masoom Yasinzai, Jiancun Zhang, Jamshed Iqbal, Shahid Hameed

BIOORGANIC CHEMISTRY (2020)

Article Biophysics

An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids

Omar Mukama, Jinghua Wu, Zhiyuan Li, Qiongxin Liang, Zhijian Yi, Xuewen Lu, Yujie Liu, Yumei Liu, Muzammal Hussain, Gaelle Guiewi Makafe, Jiaxin Liu, Ning Xu, Lingwen Zeng

BIOSENSORS & BIOELECTRONICS (2020)

Article Chemistry, Analytical

A high fidelity CRISPR/Cas12a based lateral flow biosensor for the detection of HPV16 and HPV18

Omar Mukama, Ting Yuan, Zhixu He, Zhiyuan Li, Jean de Dieu Habimana, Muzammal Hussain, Wei Li, Zhijian Yi, Qiongxin Liang, Lingwen Zeng

SENSORS AND ACTUATORS B-CHEMICAL (2020)

Article Chemistry, Multidisciplinary

Sustainable Approach to Azaheterocyclic Acetamides by Decarboxylative Aminoformylation

Zhenxing Zhang, Chunqi Jia, Xiangtao Kong, Muzammal Hussain, Zhenyu Liu, Wanqing Liang, Ling Jiang, Hao Jiang, Junyan Ma

ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2020)

Article Multidisciplinary Sciences

SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury

Anteneh Getachew, Nasir Abbas, Kai You, Zhen Yang, Muzammal Hussain, Xinping Huang, Ziqi Cheng, Shenglin Tan, Jiawang Tao, Xiaorui Yu, Yan Chen, Fan Yang, Tingcai Pan, Yingying Xu, Guosheng Xu, Yuanqi Zhuang, FeiMa Wu, Yinxiong Li

Summary: The study found that serum amyloid A1 (SAA1) acts as a chemokine to recruit hepatic stellate cells (HSCs) towards injury loci through the TLR2 receptor, initiating PI3K-dependent signaling and regulating cell directional migration.

ISCIENCE (2021)

Review Medicine, Research & Experimental

Toll-like receptor 2 signaling in liver pathophysiology

Anteneh Getachew, Muzammal Hussain, Xinping Huang, Yinxiong Li

Summary: Chronic liver diseases are a major global cause of mortality, with chronic alcohol abuse and high-fat diet contributing to severe liver disease. Understanding signaling pathways such as TLR2 in hepatic disease development is crucial, as targeting this pathway may alleviate disease-related functioning.

LIFE SCIENCES (2021)

Article Multidisciplinary Sciences

A small-molecule Skp 1 inhibitor elicits cell death by p53-dependent mechanism

Muzammal Hussain, Yongzhi Lu, Muqddas Tariq, Hao Jiang, Yahai Shu, Shuang Luo, Qiang Zhu, Jiancun Zhang, Jinsong Liu

Summary: Skp1 overexpression promotes tumor growth, while reduced Skp1 activity is linked to genomic instability and neoplastic transformation. This study identifies Z0933M as a potent Skp1 inhibitor that disrupts SCF E3 ligase functioning and induces cell death. Z0933M could be a valuable tool for exploring Skp1 cancer biology and has implications for cancer therapy.

ISCIENCE (2022)

Article Infectious Diseases

Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China

H. M. Adnan Hameed, Cuiting Fang, Zhiyong Liu, Yanan Ju, Xingli Han, Yamin Gao, Shuai Wang, Gift Chiwala, Yaoju Tan, Ping Guan, Jinxing Hu, Xiaoli Xiong, Jiacong Peng, Yongping Lin, Muzammal Hussain, Nanshan Zhong, Dmitry A. Maslov, Gregory M. Cook, Jianxiong Liu, Tianyu Zhang

Summary: This study investigated the prevalence of mutations in the rpoB gene of Mycobacterium tuberculosis clinical isolates and their association with rifampicin resistance. The results showed that mutations in the gene were common in rifampicin-resistant strains, with some mutations occurring in the RRDR region and others occurring outside the RRDR. GeneXpert MTB/RIF and sequencing analysis were effective in the rapid molecular diagnosis of rifampicin resistance. These findings are important for the early detection of tuberculosis and the recommendation of appropriate treatment regimens.

INFECTION AND DRUG RESISTANCE (2022)

Article Biochemistry & Molecular Biology

Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate Kinase

Gaelle G. Makafe, Muzammal Hussain, Goverdhan Surineni, Yaoju Tan, Nai-Kei Wong, Mugweru Julius, Lanying Liu, Chiwala Gift, Huofeng Jiang, Yunxiang Tang, Jianxiong Liu, Shouyong Tan, Zhijun Yu, Zhiyong Liu, Zhili Lu, Cuiting Fang, Yang Zhou, Jiancun Zhang, Qiang Zhu, Jinsong Liu, Tianyu Zhang

CELL CHEMICAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Design, synthesis, and in vitro biological evaluation of novel benzimidazole tethered allylidenehydrazinylmethylthiazole derivatives as potent inhibitors of Mycobacterium tuberculosis

Goverdhan Surineni, Yamin Gao, Muzammal Hussain, Zhiyong Liu, Zhili Lu, Chiranjibi Chhotaray, Md Mahmudul Islam, H. M. Adnan Hameed, Tianyu Zhang

MEDCHEMCOMM (2019)

Review Biochemistry & Molecular Biology

Hazardous Effects of Titanium Dioxide Nanoparticles in Ecosystem

Syed Niaz Ali Shah, Zahir Shah, Muzammal Hussain, Muzaffar Khan

BIOINORGANIC CHEMISTRY AND APPLICATIONS (2017)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)